Antihistamines and Topiramate-Induced Angle Closure

Introduction to Angle Closure Mechanisms

The American Academy of Ophthalmology notes that antihistamines with anticholinergic properties can precipitate acute angle closure glaucoma in patients with anatomically narrow angles, but topiramate causes angle closure through a completely different mechanism, making the combination no more dangerous than either drug alone in susceptible individuals 1, 2

Topiramate induces ciliary body edema that causes forward displacement of the lens-iris diaphragm, resulting in secondary angle closure, according to the American Academy of Ophthalmology 1, 2

Anticholinergic medications, including some antihistamines, cause angle closure through pupillary dilation in patients with pre-existing anatomically narrow angles, as stated by the American Academy of Ophthalmology 1, 2
They work by causing mid-pupillary dilation that bunches peripheral iris tissue into the angle, posing a risk particularly high in hyperopic, older phakic patients with shallow anterior chambers, according to the American Academy of Ophthalmology 1, 2

The American Academy of Ophthalmology recommends that if the patient has anatomically narrow angles, both topiramate and anticholinergic antihistamines pose independent risks, and ophthalmologic evaluation with gonioscopy should precede use of either medication class 1, 2
Consider prophylactic laser peripheral iridotomy if narrow angles are confirmed and these medications are necessary, as suggested by the American Academy of Ophthalmology 1, 2

Watch for acute angle closure symptoms in any patient on topiramate or anticholinergic antihistamines, including eye pain, redness, and decreased vision, halos around lights and blurred vision, according to the American Academy of Ophthalmology 1, 2

The American Academy of Ophthalmology states that anticholinergic cases of angle closure should be treated by stopping the offending agent, using miotics, and considering laser peripheral iridotomy for definitive treatment 1, 2

Angle-closure glaucoma is less common, characterized by narrowed iridocorneal angles that can become blocked 3
The risk of angle-closure glaucoma is particularly high for patients with anatomically narrow anterior chamber angles 4, 3
The risk of angle-closure glaucoma is also high for patients with a history of intermittent angle closure symptoms, such as blurred vision, halos around lights, and eye pain 4, 3
Hyperopia, especially in older phakic patients, is also a risk factor for angle-closure glaucoma 3

For patients with risk factors for angle closure but no diagnosis, ophthalmologic evaluation should precede any consideration of anticholinergic therapy 5
Monitor for signs of angle-closure glaucoma in all patients taking medications with anticholinergic effects, including eye pain, blurred vision, and halos around lights 6